WHO recommends Eli Lilly, GSK-Vir's drugs, widening Covid-19 treatment pool

A World Health Organization (WHO) panel recommended the use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for Covid-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective.

WHO data shows Omicron, which is evading protection provided by many vaccines and therapies, has been identified in 149 countries. It is quickly replacing Delta as the dominant variant in several nations, forcing governments and scientists to bolster defences with testing, shots and therapies.